FIELD: immunology, microbiology, genetic and protein engineering. SUBSTANCE: invention relates to immunogens and antigens of Haemophilus species. Isolated and purified analogue of Hin47 protein from Haemophilus influenzae exhibits decreased protease activity that is less 10% of activity of natural protein Hin47 but the same immunogenic properties as natural protein due to substitution or incorporation of at least one amino acid in native protein determining protease activity. Amino acid can be taken among amino acids 195-201, His-91 or Asp- 121 of native protein Hin47. Chimeric molecule comprises analogue of protein Hin47 of Haemophilus influenzae bound with polysaccharide. Recombinant plasmid DS-1011-1-1 (pT7/Hin47*) carries nucleic acid molecule expressing analogue of protein Hin47 with substitution of Ser-197 for alanine. At least a single amino acid residue of protein Hin47 determining protease activity is identified. For removal or substitution of nucleotide sequence encoding this amino acid site-directed mutagenesis of gene hin47 is carried out. Mutant gene is incorporated into cell to obtain transformed cell and the latter is cultured to yield analogue of Hin47. Immunogenic composition comprises effective amount of analogue Hin47. Interaction of sample with analogue Hin47 is carried out to obtain complexes comprising analogue Hin47 and recognizing its antibodies specifically if they present in sample. In subject immunization antibodies exhibiting specificity to protein Hin47 are obtained. Interaction of sample with antibodies is carried out. Diagnostic set for assay of antibodies presence that are able to recognize protein Hin47 specifically comprises in sample analogue of protein Hin47 and agents providing interaction of analogue with sample. Invention ensures to obtain vaccine preparations against sicknesses caused by pathogenic microorganism Haemophilus influenzae. EFFECT: improved method of preparing, valuable biological and medicinal properties. 18 cl, 25 dwg, 3 tbl, 14 ex
Title |
Year |
Author |
Number |
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY |
1993 |
- Pele Chong
- Vejn Tomas
- Jan-Ping Jang
- Shina Lusmore
- Du Juan Charlz Sia
- Majkl Klejn
|
RU2141528C1 |
DNA FRAGMENT ENCODING TRANSFERRIN RECEPTOR PROTEIN FRAGMENT OF STRAIN HAEMOPHILUS (VARIANTS), PLASMID VECTOR (VARIANTS), RECOMBINANT PROTEIN (VARIANTS), ISOLATED AND PURIFIED PROTEIN (VARIANTS), IMMUNOGENIC COMPOSITION AND METHOD OF ISOLATION AND PURIFICATION OF PROTEIN |
1994 |
- Luzmor Shina
- Kharkness Robin
- Shriverz Ehntoni
- Chong Pele
- Grej-Ouehn Skott
- Jang Jan-Ping
- Merdin Ehndrju
- Klejn Majkl
|
RU2194757C2 |
SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE (VARIANTS), METHOD OF OLIGOMER PREPARING, POLYSACCHARIDE PROTECTED BY SOLID POLYETHYLENE GLYCOL MONOMETHYL ESTER |
1993 |
- Pele Chong
- Ali Kandil
- Charl'Z Saja
- Majkl Kh.Klejn
|
RU2141527C1 |
GENES ENCODING MORAXELLA TRANSFERRIN RECEPTOR |
1997 |
- Majers Lajza E.
- Shrivers Ehntoni B.
- Khehrkness Robin E.
- Lusmor Shina M.
- Du Ran-Pehn
- Jang Jan-Ping
- Klajn Majkl Kh.
|
RU2235128C2 |
METHOD OF ISOLATION AND PURIFICATION OF PROTEIN OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE, STRAIN MORAXELLA CATARRHALIS FOR PREPARING PROTEIN CD, ISOLATED AND PURIFIED NONDENATURATED PROTEIN CD OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE AND IMMUNOGENIC COMPOSITION COMPRISING PROTEIN CD OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE |
1995 |
- Jang Jan-Ping
- Khakness Robin E.
- Majers Liza E.
- Makginness Ursula
- Klejn Majkl Kh.
|
RU2186582C2 |
HYBRID PROTEIN, HYBRID GENE, METHOD OF PREPARING A HYBRID PROTEIN, VACCINE AGAINST UPPER RESPIRATORY WAY VIRAL DISEASE, BACULOVIRAL EXPRESSION VECTOR (VARIANTS) |
1993 |
- Mishel Kh.Klejn
- Run-Pan Du
- Meri E.Ehvazishin
|
RU2123047C1 |
POLYVALENT ASSOCIATED DIPHTHERIA, TETANUS TOXOIDS AND PERTUSSIS POLIOVIRUS VACCINES |
1997 |
- Fakhim Raafat E.F.
- Tehn Lehrri Ju.L.
- Barreto L'Juis
- Tippkhavong Dzhon
- Dzhekson Gejl E.D.
|
RU2194531C2 |
SYNTHETIC HIV PEPTIDE (VARIANTS), IMMUNOGENIC COMPOSITION FOR INDUCTION OF IMMUNE RESPONSE AGAINST HIV PEPTIDES, DIAGNOSTIC SET FOR ASSAY OF HIV-SPECIFIC ANTIBODIES |
1994 |
- Sia Charlz D.I.
- Chong Pele
- Klejn Majkl Kh.
|
RU2201421C2 |
INACTIVATED VACCINES OF RESPIRATORY-SYNTYTIAL VIRUS |
1994 |
- Sonja E.Sankhuehza
- Mehri Ehlizabet Ivasishin
- Michel Genri Klejn
|
RU2142817C1 |
RESPIRATORY-SYNCYTIAL VIRUS SUBUNIT VACCINE PREPARATION |
1997 |
- Kejts Dzhordzh A.
- Sanuehza Sonja E.
- Oomen Rajmond P.
- Klajn Mishel' Kh.
|
RU2243234C2 |